A single oral dose of azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally by one-third, according to a large multi-country published in the New England Journal of Medicine.
A single oral dose of azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally by one-third, according to a large multi-country published in the New England Journal of Medicine.
Read MoreThe target action date for the FDA’s approval decision is set for the third quarter. If approved, nirsevimab is expected to be available in the US for the 2023/2024 RSV season.
Read MoreFour months of treatment with rifapentine and moxifloxacin for tuberculosis was as effective as the standard six-month regimen, according to research reported in the New England Journal of Medicine.
Read More
Research published in The New England Journal of Medicine shows that lung cancer deaths have been decreasing.
Read More
Science Magazine investigates the latest medications that are targeting respiratory syncytial virus (RSV).
Read More
